Tobey MacDonald
Emory University · Children's Oncology Group · Pediatric Brain Tumor Consortium
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tobey MacDonald as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:19 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06624371 · Atovaquone Combined With Radiation in Children With Malignant Brain TumorsEmory University · recruiting · High-grade Glioma, Medulloblastoma, Diffuse Intrinsic Pontine Glioma · principal investigator
- Ph1NCT04334863 · WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain TumorsEmory University · completed · Brain Tumor, Medulloblastoma, Brain Metastases · principal investigator
- Ph2NCT00679354 · Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNational Cancer Institute (NCI) · completed · Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Recurrent Childhood Anaplastic Astrocytoma · principal investigator
- Ph1NCT00063973 · Cilengitide in Treating Children With Refractory Primary Brain TumorsNational Cancer Institute (NCI) · completed · Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor, Childhood Craniopharyngioma · principal investigator
- N/ANCT00010114 · Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young ChildrenPediatric Brain Tumor Consortium · completed · Central Nervous System Embryonal Neoplasm · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The Role of PDGFR in Medulloblastoma ProgressionR01CA111835 · NCI · EMORY UNIVERSITY · fiscal years 2006 to 2010 · $240,431 awarded in 2010Same name and institution; not confirmed by an ID
- PHASE II STUDY OF BEVACIZUMAB PLUS IRINOTECAN (CAMPTORSAR) IN CHILDREN WITH RECRM01RR020359 · NCRR · CHILDREN'S RESEARCH INSTITUTE · fiscal years 2005 to 2008 · $4,791 awarded in 2008Same name and institution; not confirmed by an ID
- Regulation- Medulloblastoma Growth by alpha-v integrinsK08CA092056 · NCI · CHILDREN'S RESEARCH INSTITUTE · fiscal years 2002 to 2006 · $125,721 awarded in 2006Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT00679354
- Pediatric Brain Tumor Consortium (PBTC)U01CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI JAMES Milford BOYETT · fiscal years 1999 to 2013Named on NCT00063973
Most cited trial papers
Clinical-trial papers with this author name in diffuse midline glioma (dipg), ranked by citations from NIH iCite, fetched 2026-11-12 10:19 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.Neuro Oncol · 202449 citationsRCR 6.1
- Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.Neuro Oncol · 202423 citationsRCR 2.9